| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7389973 | Value in Health Regional Issues | 2017 | 10 Pages |
Abstract
Despite its higher acquisition cost, edoxaban is an economically attractive alternative to warfarin for the prevention of stroke and SEE in patients with AF in Taiwan.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Katherine A. MPH, Ming Chin DrPH, Elise Chia PhD, Kaijun PhD, Haiyan MS, Wan Hsuan MSc, Robert P. Giugliano, David J. Cohen, Elizabeth A. ScD, on behalf of the ENGAGE AF - TIMI 48 Investigators on behalf of the ENGAGE AF - TIMI 48 Investigators,